Purification of HA-tagged P2Y 2 receptors from transfected human 1321N1 astrocytoma cells yielded a protein with a molecular size determined by SDS-PAGE to be in the range of 57-76 kDa, which is typical of membrane glycoproteins with heterogeneous complex glycosylation. The protein phosphatase inhibitor, okadaic acid, attenuated the recovery of receptor activity from the agonist-induced desensitized state, suggesting a role for P2Y 2 receptor phosphorylation in desensitization. Isolation of HAtagged P2Y 2 nucleotide receptors from metabolically [ 32 P]-labelled cells indicated a (3.8±0.2)-fold increase in the [ 32 P]-content of the receptor after 15 min of treatment with 100 µM UTP, as compared to immunoprecipitated receptors from untreated control cells. Receptor sequestration studies indicated that ∼40% of the surface receptors were internalized after a 15-min stimulation with 100 µM UTP. Point mutation of three potential GRK and PKC phosphorylation sites in the third intracellular loop and Cterminal tail of the P2Y 2 receptor (namely, S243A, T344A, and S356A) extinguished agonist-induced receptor phosphorylation, caused a marked reduction in the efficacy of UTP to desensitize P2Y 2 receptor signalling to intracellular calcium mobilization, and impaired agonist-induced receptor internalization. Activation of PKC isoforms with phorbol 12-myristate 13-acetate that caused heterologous receptor desensitization did not increase the level of P2Y 2 receptor phosphorylation. Our results indicate a role for receptor phosphorylation by phorbol-insensitive protein kinases in agonist-induced desensitization of the P2Y 2 nucleotide receptor. (Mol Cell Biochem 280: 35-45, 2005) 
Introduction
The heptahelical P2Y 2 nucleotide receptor couples to the activation of mitogen-activated protein kinases (MAPK), the mobilization of intracellular stores of calcium, the activation of phospholipase C-β (PLC-β), protein kinase C (PKC) isoforms, focal adhesion kinase, and c-Src kinase, and has been implicated in a number of physiological and pathological processes including inflammation [1, 2] , reactive astrogliosis [3] , and neuroprotection [4] . Nucleotides acting through the P2Y 2 receptor have been shown to induce Cl − secretion in airway epithelial cells that is not dependent on the cystic fibrosis transmembrane-conductance regulator [5] , and P2Y 2 receptor ligands have been proposed as a novel class of medication for treatment of retinal detachment [6] and improved mucociliary clearance in clinical conditions such as cystic fibrosis [7] .
There is limited information regarding the regulation of signalling by the P2Y 2 nucleotide receptor. Like in other G protein-coupled receptors (GPCRs), the P2Y 2 nucleotide receptor signalling is regulated by agonist-induced desensitization [8, 9] . The mechanisms of GPCR desensitization have been studied most extensively with the β 2 -adrenergic receptor [10, 11] . G protein-coupled receptor kinase (GRK)-mediated phosphorylation increases the binding of cytosolic proteins termed arrestins to the β 2 -adrenergic receptor, leading to its internalization [12] [13] [14] [15] [16] . It has been shown that GRK-mediated phosphorylation targets the arrestin-bound β 2 -adrenergic receptor towards sequestration via clathrincoated pits [17] . Truncation of GPCR C-terminal regions containing consensus sequences for potential phosphorylation by GRKs has been shown to impair β 2 -adrenergic receptor sequestration [14] .
The P2Y 2 nucleotide receptor is a G q protein-coupled receptor that is stimulated equipotently by UTP and ATP, mediating activation of phospholipase C-β (PLC-β) and MAPK [18, 19] . We have previously reported that the P2Y 2 receptor undergoes rapid agonist-induced desensitization [8, 9, 20] . Significantly, treatment of desensitized cells with the protein phosphatase inhibitor, okadaic acid, inhibited resensitization of the receptor, suggesting a role for protein phosphorylation in the regulation of P2Y 2 receptor signalling [9, 20] . Moreover, truncation mutants indicated an important role for the C-terminal tail of the P2Y 2 receptor in desensitization and sequestration of the receptor [8] .
In this paper, we have investigated the UTP-induced desensitization, phosphorylation and sequestration of a hemagglutinin (HA) epitope-tagged P2Y 2 receptor transfected in 1321N1 human astrocytoma cells. Antibodies directed towards the HA-tag facilitated detection of the P2Y 2 receptor by flow cytometry, confocal microscopy, immunoprecipitation, and Western blot in sequestration and phosphorylation assays. Agonist-induced desensitization of the P2Y 2 receptor mediated Ca 2+ mobilization correlated with an increase in receptor phosphorylation and sequestration. We confirmed that inhibition of protein phosphatases with okadaic acid decreased receptor resensitization. Furthermore, point mutation of potential sites for GRK and PKC phosphorylation diminished agonist-induced phosphorylation and internalization of the P2Y 2 receptor, and the efficacy of UTP to induce desensitization. Interestingly, heterologous desensitization induced by phorbol 12-myristate 13-acetate occurred in the absence of increased receptor phosphorylation. This study yields a better understanding of the molecular mechanisms for desensitization of the P2Y 2 nucleotide receptor.
Experimental procedures

Materials
[ 32 P]-orthophosphate (HCl-free, carrier-free) and Protein ASepharose CL-4B were purchased from Amersham Pharmacia Biotech. Anti-HA 12CA5 and Anti-HA-peroxidase 3F10 monoclonal antibodies were provided by Roche Molecular Biochemicals. Horse radish peroxidase-protein markers for Western blots were purchased from New England Biolabs. Phosphate-free Dulbecco's modified Eagle's medium (DMEM) and Geneticin were supplied by Invitrogen Life Technologies. Tissue culture reagents were from Hyclone. All other reagents were obtained from Sigma.
P2Y 2 receptor gene cDNA construct
The P2Y 2 receptor cDNA was subcloned into the retroviral vector pLXSN at the EcoRI/BamHI sites of the multiple cloning site. The open reading frame of the P2Y 2 receptor cDNA was modified using polymerase chain reaction to include the hemagglutinin (HA) epitope (YPY-DVPDYA) from influenza virus at the amino terminus of the expressed protein, as described previously [8] . The forward and reverse HA primers designed for this study were (HA-tag encoded by underlined sequence): 5 -gatcgtgaattctgatgtatccatatgatgttccagattatgctgcagcagacctggaaccctgg-3 and 5 -gatcgtggatcccctgactgaggtgctatagccg-3 , respectively. A mutant P2Y 2 receptor was constructed by changing serine-243, threonine-344, and serine-356 to alanine (AAA-P2Y 2 ). Recombinant cDNA constructs were sequenced on both strands to ensure that mutagenesis had occurred as expected using an ABI Prism automated sequencing apparatus (Perkin-Elmer) and fluorescence dideoxynucleotide technology.
Cell culture and transfection
1321N1 astrocytoma cells were grown in DMEM supplemented with 5% Fetalclone III bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, 5 mM Hepes and 500 µg/ml Geneticin (G418) [21] . Cells were seeded at 2.5×10 6 per 75 cm 2 tissue culture flasks and grown to ∼90% confluency in a humidified atmosphere of 5% CO 2 and 95% air. The 1321N1 cells were transfected with HA-tagged P2Y 2 receptor cDNA using the pLXSN retroviral vector as described previously [22] .
Intracellular free calcium ion mobilization
Activation of the P2Y 2 receptor was monitored by detecting changes in intracellular free calcium ion concentration (i.e. [Ca 2+ ] i ) in fura2 labelled 1321N1 cells using a dualexcitation spectrofluorimeter, as described previously [9, 23] . Cells were assayed in 15 mM Hepes-buffered saline (pH 7.4) containing 1 mM CaCl 2 , 1 mM MgCl 2 , 0.1% (w/v) bovine serum albumin (BSA), and 10 mM glucose. Desensitization experiments were performed by incubating the transfected 1321N1 cell suspension with varying concentrations of UTP or PMA for 15 min at 37
• C. The cells were pelleted in a microcentrifuge and resuspended in 2 ml Hepes buffer. A concentration of UTP equal to the EC 50 value for each cell line was used to rechallenge the cells in receptor desensitization experiments. Calcium mobilization is reported as a ratio relative to the maximal response. Concentration-response data were analysed with the Prism curve-fitting program (Graph-PAD Software for Science, San Diego, CA).
Receptor immunoprecipitation
Human 1321N1 cells were seeded at 2.5 × 10 6 cells/25 ml in 25 mm × 150 mm tissue culture dishes and allowed to grow to ∼90% confluency. On the day of the experiment, each cell monolayer was washed two times with 5 ml of serum-free DMEM, leaving 5 ml of the medium over the cells. Then, the cells were either stimulated for 15 min with 100 µM UTP or control-treated with serum-free medium. The culture dishes were placed on ice and the medium was aspirated followed by two washes with ice-cold PBS. The final wash was aspirated and 700 µl of RIPA Buffer (2×) [300 mM NaCl, 100 mM Tris-HCl, 10 mM EDTA, 2% (v/v) NP-40, 1% (w/v) sodium deoxycholate, 0.2% (w/v) SDS, 20 mM NaF, 20 mM disodium pyrophosphate, 20 µg/ml of each benzamidine, leupeptin, and soybean trypsin inhibitor, 10 µg/ml aprotinin, 2 µg/ml pepstatin A, and 0.2 mM PMSF, pH 8] was added. The cells were scraped in this volume and solubilized for 1 h at 4
• C with gentle rocking. After solubilization, the extract was centrifuged at 200,000 ×g for 45 min at 4
• C. The supernatant was mixed with 100 µl 10% (w/v) Protein ASepharose prepared in 3% BSA/RIPA (1×) buffer and incubated for 1 h at 4
• C with gentle rocking. The suspension was centrifuged at 12,000 ×g for 2 min at 4
• C and the precleared supernatant was mixed with 50 µg anti-HA antibody and 100 µl 10% Protein A-Sepharose. The samples were incubated overnight at 4
• C with gentle rocking. On the next day, the gel matrix was washed three times using RIPA (1×) buffer at 4
• C and the final pellet was resuspended in 50 µl SDS Loading Buffer (1×). The samples were incubated at 65
• C for 10 min to elute the antigen-antibody complexes and the gel matrix was pelleted as before. The supernatant was removed and saved at −20
• C until SDS-PAGE (10%) analysis was performed.
SDS-PAGE and Western blot
The immunoprecipitated samples were analysed in a 10% sodium dodecyl sulfate-polyacrylamide gel. Proteins were transferred electrophoretically to nitrocellulose membranes using tris-glycine transfer buffer and 15 V constant voltage in a Semi-dry Transfer System (Bio-Rad) for 1.5 h. The nitrocellulose membrane was blocked for 1 h with 5% nonfat dry milk in PBS-0.1% Tween 20 pH 7.2 (PBS-T), followed by three quick rinses with PBS-T. The membrane was then incubated with 1 µg of anti-HA-peroxidase 3F10 antibody (Roche Molecular Biochemicals) in 10 ml of 5% nonfat dry milk in PBS-T pH 7.2 for 1 h at room temperature or overnight at 4
• C with gentle agitation. Anti-biotin-peroxidase (10 µl, New England BioLabs) was also added in order to detect the biotinylated protein standards. The membrane was washed three times for 10 min with PBS-T before adding the luminol detection solution (SuperSignal West Dura, Pierce). The drained nitrocellulose membrane covered with plastic wrap was exposed for 15 min to the Molecular Imager Screen-CH (GS-525 Bio-Rad, Hercules, CA) for chemiluminescence analysis of total protein.
Receptor phosphorylation
HA-tagged P2Y 2 transfected 1321N1 cells (P2Y 2 -1321N1) were seeded and grown as mentioned in the receptor immunoprecipitation assay. On the day of the experiment, each cell monolayer was washed two times with 5 ml of phosphatefree, serum-free DMEM, leaving 5 ml of the medium over the cells. Then, 2.5 mCi of [ 32 P]-orthophosphate was added to each dish and incubated at 37
• C for 2 h. Okadaic acid (1 µM final concentration) was added 10 min prior to the UTP or PMA, which was incubated for the final 15 min of the 2 h labelling period according to Freedman et al. [24] . The P2Y 2 receptor was immunopurified and analysed by SDS-PAGE and Western blot as described earlier. Phosphorylation data was acquired prior to chemiluminescence analysis by exposing the nitrocellulose membrane to the Molecular Imager Phosphor Screen-BI TM (GS-525 Bio-Rad, Hercules, CA) for 18 h. Total protein was determined via chemiluminescence by exposing the same membrane to the Molecular Imager Screen-CH for 15 min after visualization of bands with anti-HA peroxidase-coupled antibodies as described earlier. Phosphorylation data were normalized to total protein data by dividing [ 32 P] counts by chemiluminescence counts.
Flow cytometry sequestration assay
The procedure was performed essentially as described previously [8] . Briefly, P2Y 2 -1321N1 cells were grown to ∼90% confluency in 35-mm culture dishes and incubated with 100 µM UTP for various time periods. Control cells were incubated without UTP to allow an estimation of the total detectable cell-surface P2Y 2 receptors. UTP-treated cells were then washed with ice-cold Hepes buffer and incubated at 4
• C for 1 h with the same buffer containing 10 µg of anti-HA 12CA5 antibody. The cells were washed and incubated with PBS containing 30 µg/ml of F c -specific fluorescein isothiocyanate (FITC)-labelled goat anti-mouse antibody (Sigma) in the dark at 4
• C for 1 h. Control cells were incubated with primary or secondary antibody alone to detect any non-specific fluorescence. The PBS-washed P2Y 2 -1321N1 cells were detached from the dishes using Hepes buffer containing 2 mM EDTA. They were centrifuged and resuspended in 1 ml of 1% (v/v) formaldehyde in PBS and incubated in the dark at 4
• C for 10 more minutes. Finally, the cells were centrifuged and resuspended in 0.5 ml PBS, and analysed on an EPICS 753 flow cytometer (Coulter Corp., Hialeah, FL) with a 5 W argon laser tuned at 488 nm using 150 mW output.
Confocal microscopy
Human 1321N1 cells transfected with either wild type or AAA mutant P2Y 2 R were cultured in Laboratory-Tek chamber slides (Nalge Nunc Int., Rochester, NY, USA) for 3 days in culture medium. On the day of the assay, cells were equilibrated in serum-free medium for 1 h at 37
• C. Non-specific protein sites were blocked with 1% (w/v) bovine serum albumin in PBS (blocking buffer) for 15 min at 4
• C. Cells were then incubated with 10 µg/ml anti-HA mouse monoclonal antibody (Roche Molecular Biochemicals) in blocking buffer for 1 h at 4
• C to form receptor/antibody complexes and washed three times with ice-cold PBS. Cells were incubated with or without 10 µM UTP at 37
• C for 5, 15 or 30 min. The cells were washed three times with ice-cold PBS and fixed with 2% formaldehyde in PBS for 10 min at room temperature. The HA-tagged receptors were detected by incubation with Alexa Fluor 488-conjugated anti-mouse IgG secondary antibody (Molecular Probes) for 60 min at room temperature. Plasma membrane staining with Wheat Germ AgglutininTexas Red (Molecular Probes) was performed as described by Holloway et al. [25] . Images were acquired using a Zeiss (Thornwood, NY, USA) LSM-5 Pascal scanning confocal microscope equipped with an Alpha-Fluar 100 × 1.45 DIC oil immersion objective. Argon and helium-neon lasers were used for excitation of Alexa Fluor 488 and Texas Red, respectively. Emission from Alexa Fluor 488 and Texas Red was detected with BP 505-530 and LP 560 filters, respectively using multitracking scan mode. P2Y 2 2). Vector-transfected 1321N1 cells yielded no immunoprecipitated products nor did the eluent from washed Sepharose matrix (Fig. 1, lanes 3 and 4, respectively) . No bands were detected in a sample consisting of 12CA5 anti-HA antibody indicating that the detected bands originated from the P2Y 2 -1321N1 cells and were not contaminants introduced by the antibody used in the immunoprecipitation protocol (Fig. 1,  lane 6 ).
Agonist-induced P2Y 2 receptor desensitization involves phosphorylation
Extracellular UTP caused a concentration-dependent activation of P2Y 2 receptors that mediated rapid and transient increases in intracellular free calcium ion concentration ([Ca 2+ ] i ) as previously reported [9] . The agonist concentration that produces 50% of the response (EC 50 value) was 0.32 µM (log EC 50 = −6.5 ± 0.1) ( Table 1) . Desensitization of the UTP-induced calcium response was determined after a 15-min pretreatment of the cells with various UTP concentrations. The desensitization was rapid and the agonist concentration that inhibits 50% of the response (IC 50 value) was 6.3 µM (log IC 50 = −5.2 ± 0.2) ( Table 1) . Flow cytometry sequestration analysis of HA-tagged P2Y 2 receptors was performed using mouse anti-HA 12CA5 antibody and fluorescein isothiocyanate (FITC)-labelled goat anti-mouse antibody. About 40% of the receptors were sequestered within 15 min of incubation with 100 µM UTP (Fig. 2) . Previous reports have suggested that receptor phosphorylation plays a role in the modulation of P2Y 2 receptor desensitization and recovery [9, 20] . Consistent with this idea, we observed that recovery of P2Y 2 receptor signalling after agonist-induced desensitization was inhibited by 50% upon Fig. 2 . UTP-induced sequestration of P2Y 2 receptors expressed in 1321N1 cells. Human 1321N1 cells expressing HA-tagged P2Y 2 receptors were incubated at 37 • C with 100 µM UTP for the indicated times. Control cells were incubated without UTP to determine the total detectable cell-surface P2Y 2 receptors. The cells were washed in assay buffer and incubated with Fc-specific fluorescein isothiocyanate (FITC)-labelled goat anti-mouse antibody at 4 • C in the dark for 1 h. Cells were washed again and analysed by flow cytometry as described in Experimental Procedures. Each value shown is expressed as a percentage of the total P2Y 2 receptors detected in control cells that were treated with UTP-free carrier buffer. The data presented are the average ± S.E.M. of results from three independent experiments. treatment with 1 µM of the protein phosphatase inhibitor okadaic acid (Fig. 3) . Okadaic acid treatment had no effect on receptor desensitization. However, to directly assess phosphorylation of the P2Y 2 receptor, we developed a receptor phosphorylation assay using an immunopurification protocol to examine metabolically [ 32 P]-orthophosphate labelled P2Y 2 -1321N1 cells. Treatment of [ 32 P]-orthophosphate labelled cells with 100 µM UTP agonist caused a significant increase in the [ 32 P]-radioactivity associated with immunoprecipitated proteins in the 57-76 kDa region as compared to control unstimulated cells (Fig. 4A) .
The [ 32 P]-radioactivity data was normalized to the total protein detected by chemiluminescence analysis of the same nitrocellulose membrane using anti-HA-peroxidase antibody and a luminol substrate. Thus, the ratio of [ 32 P]-radioactivity counts to chemiluminescence counts was determined for immunoprecipitated samples from UTP-treated cells and control unstimulated cells (Fig. 4B) . A (3.8 ± 0.2)-fold increase in [ 32 P]-content (phosphorylation) was obtained for the P2Y 2 receptor after 15 min of stimulus with UTP.
Elimination of potential GRK and PKC phosphorylation sites attenuates agonist-induced but not phorbol ester-induced P2Y 2 receptor desensitization and phosphorylation
Examination of the primary structure of the P2Y 2 receptor revealed the presence of serine and threonine residues within (A) (B) Fig. 4 . UTP-induced phosphorylation of P2Y 2 receptors. Human 1321N1 cells expressing the HA-tagged P2Y 2 receptor gene were metabolically labelled with [ 32 P]-orthophosphate for 2 h in serum-free and phosphate-free medium and then challenged with 100 µM UTP for 15 min as described in Experimental Procedures. Control-unstimulated cells were challenged with carrier medium. Cells were lysed and detergent-solubilized cell extracts were analysed by anti-HA immunoprecipitation, SDS-PAGE (10%), and Western blot. The [ 32 P]-radioactivity data were acquired prior to chemiluminescence analysis by exposing the nitrocellulose membrane to the Molecular Imager Screen-BI for 18 h. Total protein in the membrane was then analysed after chemiluminescence detection by incubating the same nitrocellulose membrane with peroxidase-conjugated anti-HA antibody followed by luminol substrate incubation and exposure to the Molecular Imager Screen-CHEMI for 15 min. GRK/PKC consensus substrate sequences [26, 27] in the intracellular domains [28] . A mutant HA-tagged P2Y 2 receptor was constructed by changing serine-243, threonine-344 and serine-356 to alanine (AAA-P2Y 2 ) to test the hypothesis that phosphorylation of the P2Y 2 receptor may be implicated in agonist-induced desensitization. We transfected the AAA-P2Y 2 receptor cDNA into 1321N1 cells and tested the receptor's capacity to signal through calcium mobilization and its desensitization. The AAA-P2Y 2 receptor induced the mobilization of intracellular stores of calcium with an EC 50 value for UTP of 0.20 µM (log EC 50 = −6.7 ± 0.1) ( Table 1 ) which is comparable to that for the wild type P2Y 2 receptor (WT-P2Y 2 ). Desensitization of the Ca 2+ response was determined in cells expressing either wild type or AAA-P2Y 2 receptors. Cells were pretreated for 15 min with various concentrations of UTP, as indicated in Fig. 5A , and then rechallenged with a concentration of UTP equal to the corresponding EC 50 value for each cell line, i.e., 0.32 and 0.20 µM for wild type and AAA-P2Y 2 receptors, respectively. Interestingly, the IC 50 value for UTP was ∼10-fold higher for the AAA-P2Y 2 receptor (IC 50 = 79 µM, log IC 50 = −4.1 ± 0.2) than for the wild type receptor (IC 50 = 6.3 µM, log IC 50 = −5.2 ± 0.2) (Fig. 5A and Table 1 ). Moreover, when cells were pretreated for 15 min with phorbol 12-myristate 13-acetate (PMA), known to activate PKC isoforms and to cause heterologous desensitization of the P2Y 2 receptor [8, 9] , we found no significant Fig. 6 . Phosphorylation of wild type and AAA-P2Y 2 receptors mediated by UTP and PMA. Human 1321N1 cells expressing either wild type or AAA-P2Y 2 receptor were labelled with [ 32 P]-orthophosphate for 2 h in serum-free and phosphate-free medium. Cells were challenged for 15 min with 100 µM UTP or 10 µM phorbol 12-myristate 13-acetate (PMA). Control unstimulated cells were treated with carrier medium. Detergent solubilized cell extracts were immunoprecipitated with anti-HA antibody followed by SDS-PAGE (10%) and Western blot as described in 'Experimental procedures'. [ 32 P]-radioactivity counts from phosphorylated proteins were normalized to chemiluminescence counts from total immunoprecipitated protein as described in Fig. 4 . Results are the mean ± S.E.M. of three separate experiments ( * * p < 0.01, significantly different from unstimulated control). difference between the IC 50 values for PMA determined in cells expressing AAA-P2Y 2 receptors (IC 50 = 2.0 µM, log IC 50 = −5.7 ± 0.3) and those expressing wild type P2Y 2 receptors (IC 50 = 3.2 µM, log IC 50 = −5.5 ± 0.2) (Fig. 5B and Table 1) .
We found that UTP-induced phosphorylation of the AAA-P2Y 2 receptor was markedly reduced as compared to (A) Fig. 7 . Internalization of wild type P2Y 2 and AAA-P2Y 2 receptors transfected in 1321N1 cells. (A) 1321N1 cells expressing either HA-tagged wild type or AAA-P2Y 2 receptors were treated with or without 10 µM UTP for 30 min as described in Experimental Procedures. Laser scanning confocal microscopy images were acquired as described in Experimental Procedures. The HA-tagged receptors were detected by immunofluorescence with Alexa Fluor 488 staining (shown in green) and cell surface N-acetylglucosamine and N-acetylneuraminic acid residues in the same cells were detected with Texas Red-conjugated wheat germ agglutinin (WGA) (shown in red). Merged images are shown. Scale bar in lower left corner = 20 µm. (B) The weighted colocalization coefficient of the HA-tagged P2Y 2 receptors with WGA was determined as described in Experimental Procedures. Receptor internalization (fraction surface HA-tagged) was determined at the indicated times after treatment with 10 µM UTP. The surface HA-tagged receptors were calculated from the ratio of WCC values to WCC in unstimulated control cells. Data presented are the average ± S.E.M. of n individual cells (as indicted inside each bar) determined from at least three independent experiments. Cells expressing wild type P2Y 2 receptors were compared to cells expressing AAA-P2Y 2 receptors ( * * * p < 0.001; ns, p > 0.05 one-way ANOVA).
(Continued on next page) the wild type P2Y 2 receptor (Fig. 6) . No increase in receptor phosphorylation was detected upon treatment with 10 µM PMA for 15 min for either wild type or AAA-P2Y 2 receptors (Fig. 6) . Importantly, agonist-induced internalization was significantly impaired in AAA-P2Y 2 receptors compared to wild type P2Y 2 receptors (Fig. 7) . Taken together, these results implicate the phosphorylation of potential GRK/PKC (B) phosphorylation sites in agonist-induced desensitization of the P2Y 2 receptor. Our data also indicate that PMA induces heterologous desensitization of the P2Y 2 receptor independent of receptor phosphorylation.
Discussion
The therapeutic potential of nucleotides and P2Y 2 receptor ligands may depend on our understanding of the desensitization process that modulates signalling by this receptor. Desensitization of GPCRs may require the activities of several protein kinases such as protein kinase A (PKA), protein kinase C (PKC) and GRKs [29, 30] . Although the molecular basis for desensitization of the adenylyl cyclase-linked β 2 -adrenergic receptor has been well characterized, less is known about the regulatory mechanisms involved in the desensitization of signalling by the P2Y 2 nucleotide receptor. Immunoprecipitation of the HA-tagged P2Y 2 receptor expressed in 1321N1 astrocytoma cells revealed a non-uniform distribution of the receptor protein that is typical of membrane glycoproteins with heterogeneous complex glycosylation (Fig. 1) . This most likely results from asparagine-linked high mannose carbohydrates as well as hybrid and complex oligosaccharides since immunoprecipitated P2Y 2 receptors were found to be susceptible to hydrolysis by peptide Nglycosidase F (data not shown). A similar heterogeneous pattern was reported for the β 2 -adrenergic receptor which has a molecular mass of 46556 and was detected in the 47-90 kDa size range [31] .
UTP-induced activation of the P2Y 2 receptor triggers the phospholipase C (PLC) signalling pathway leading to the production of inositol-1,4,5-triphosphate which increases [Ca 2+ ] i , and diacylglycerol which activates PKC. EC 50 values for UTP-induced Ca 2+ mobilization determined with the HA-tagged P2Y 2 receptor transfected cells (0.32 µM; Table 1) were similar to those obtained by us [20] for endogenous P2Y 2 receptors in human monocytic U-937 cells (0.44 µM). A 15-min treatment with 100 µM UTP produced rapid desensitization showing an IC 50 value of 6.3 µM (Table 1). We confirmed that treatment of desensitized cells with the protein phosphatase inhibitor okadaic acid (1 µM) inhibited the recovery of receptor activity from the desensitized state by ∼50% [9] , suggesting a role for P2Y 2 receptor phosphorylation in the desensitization process (Fig. 3) . These results prompted us to investigate whether UTP-induced desensitization involved an increase in receptor phosphorylation. Indeed, the P2Y 2 receptor was phosphorylated after an agonist treatment that caused desensitization and receptor internalization (Figs. 2 and 4) . These results suggest a link between receptor phosphorylation and agonist-induced desensitization. Interestingly, immunoprecipitation of detergentsolubilized total cell extracts from UTP-stimulated cells yielded an unphosphorylated ∼45 kDa protein band. Receptors from intracellular membranes (e.g. unglycosylated receptors in endoplasmic reticulum membranes) would not be accessible to extracellular ligands and thus, remain unphosphorylated upon agonist challenge.
Studies of other GPCRs have indicated the importance of the C-terminus in agonist-induced receptor regulation, since this portion of the receptor contains potential phosphorylation sites for protein kinases. For example, truncation of the C-terminus of the α 1b -adrenergic receptor decreased agonistinduced desensitization, phosphorylation and sequestration when compared to wild type receptors [32] . C-terminal truncations of other GPCRs, such as angiotensin II, neurotensin and the parathyroid hormone receptors, have been observed to inhibit receptor sequestration as well [33] [34] [35] . Studies from our laboratory have shown that the C-terminus of the P2Y 2 receptor is important for both agonist-induced desensitization and sequestration [8] . Therefore, we constructed a mutated AAA-P2Y 2 receptor by changing three potential GRK and PKC phosphorylation sites to alanine (S243, T344, S356) located in the C-terminus tail and the third intracellular loop of the P2Y 2 receptor. While the triple mutation did not affect the receptor's ability to activate calcium mobilization, it dramatically reduced the extent of phosphorylation of the receptor upon activation with agonist as well as the efficacy of agonist for inducing receptor desensitization. It is very likely that agonist-mediated homologous desensitization of P2Y 2 receptors involves protein kinases other than PMA-activated PKC isoforms, such as the GRKs, although PMA-insensitive PKC isoforms have not been ruled out. Receptor phosphorylation may modulate its affinity to agonist, its ability to couple with signal transducers, and its internalization by promoting receptor trafficking towards endocytic pathways. It is possible that PKC-mediated heterologous desensitization of the P2Y 2 receptor involves phosphorylation of signalling molecules other than the heptahelical receptor, such as phospholipase C [36] , regulator of G protein signalling (RGS) [37, 38] , and GRK2 [39, 40] .
